Summary
This prediction ended on 12.01.17 with a price of €7.64. The prediction had a final performance of 11.19%. mohabbatein has 50% into this predictionEvotec is a German-based biotech company that provides drug discovery and development solutions to pharmaceutical and biotechnology companies. The company operates in the fields of neuroscience, immunology, oncology, and infectious diseases, and its services include hit identification, target validation, and preclinical and clinical development. Evotec has partnerships with major pharmaceutical companies and has developed its own pipeline of drugs, with a focus on developing treatments for conditions such as Alzheimer's disease and diabetes. The company is listed on the Frankfurt and NASDAQ stock exchanges and has a market capitalization of approximately €5.5 billion.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evotec SE | -4.545% | -4.545% | -61.974% | -76.948% |
| iShares Core DAX® | -2.926% | -4.228% | 9.878% | 12.466% |
| iShares Nasdaq 100 | 4.462% | 8.605% | 33.063% | 59.465% |
| iShares Nikkei 225® | 0.306% | 0.284% | 3.871% | 4.557% |
| iShares S&P 500 | 2.488% | 4.773% | 27.189% | 50.113% |
Comments by mohabbatein for this prediction
In the thread Evotec AG diskutieren
mohabbatein stimmt dem Crowdsentiment von 'Buy' zu
mohabbatein stimmt am 20.12.2016 dem Buy-Crowdsentiment mit dem Kursziel 8.7€ zu.
Der Newsflow der letzten Wochen ist beeindruckend. Der kurs kommt gerade etwas zurück, aber die am laufenden Band verkündeten Kooperationen beflügeln die Fantasie und lassen noch viel Spielraum nach oben.
BUY.